Indexed keywords
BENDROFLUMETHIAZIDE;
DIURETIC AGENT;
FELBINAC;
FENOPROFEN;
IBUPROFEN;
NONSTEROID ANTIINFLAMMATORY AGENT;
ADULT;
ARTICLE;
CASE REPORT;
FOCAL GLOMERULOSCLEROSIS;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY DISEASE;
MALE;
NEPHROTIC SYNDROME;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
TOPICAL DRUG ADMINISTRATION;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
BENDROFLUMETHIAZIDE;
BIOPSY;
DIURETICS;
FENOPROFEN;
GLOMERULAR MESANGIUM;
GLOMERULOSCLEROSIS, FOCAL SEGMENTAL;
HUMANS;
HYPERTENSION;
MALE;
MIDDLE AGED;
NEPHROTIC SYNDROME;
OSTEOARTHRITIS;
PAIN;
TIME FACTORS;
1
0028176864
Renal disease and topical non-steroidal drug use
O'Callaghan CA, Andrews PA, Ogg CS. Renal disease and topical non-steroidal drug use. Br Med J 1993; 308: 110-111
(1993)
Br Med J
, vol.308
, pp. 110-111
O'Callaghan, C.A.1
Andrews, P.A.2
Ogg, C.S.3
2
0024456646
Topical non-steroidal anti-inflammatory drugs
Doogan DP. Topical non-steroidal anti-inflammatory drugs. Lancet 1989; 2: 1270-1271
(1989)
Lancet
, vol.2
, pp. 1270-1271
Doogan, D.P.1
3
0016281103
Percutaneous absorption of benzydamine in guinea pig and man
Andersson K, Larsson H. Percutaneous absorption of benzydamine in guinea pig and man. Arzneim-Forsch (Drug Res) 1974; 24: 1686-1688
(1974)
Arzneim-Forsch (Drug Res)
, vol.24
, pp. 1686-1688
Andersson, K.1
Larsson, H.2
5
0022887933
Renal syndromes associated with non-steroidal anti-inflammatory drugs: Clinical relevance
Clive DM, Stoff JS. Renal syndromes associated with non-steroidal anti-inflammatory drugs: clinical relevance. Am J Kidney Dis 1986; 8: 338-344
(1986)
Am J Kidney Dis
, vol.8
, pp. 338-344
Clive, D.M.1
Stoff, J.S.2
6
0023008761
Progression of minimal change glomerulopathy to focal glomerulosclerosis in a patient with fenoprofen nephropathy
Artinano M, Etheridge WB. Progression of minimal change glomerulopathy to focal glomerulosclerosis in a patient with fenoprofen nephropathy. Am J Nephrol 1986; 6: 353-357
(1986)
Am J Nephrol
, vol.6
, pp. 353-357
Artinano, M.1
Etheridge, W.B.2
7
0024539456
Minimal change glomerulopathy associated with non-steroidal anti-inflammatory drugs
Warren GV, Korbet SM, Schwartz MM, Lewis EJ. Minimal change glomerulopathy associated with non-steroidal anti-inflammatory drugs. Am J Kidney Dis 1989; 13: 127-130
(1989)
Am J Kidney Dis
, vol.13
, pp. 127-130
Warren, G.V.1
Korbet, S.M.2
Schwartz, M.M.3
Lewis, E.J.4
8
9444270935
Reversible membranous nephropathy associated with the use of non-steroidal anti-inflammatory drugs
Radford MG, Holley KE, Grande JP et al. Reversible membranous nephropathy associated with the use of non-steroidal anti-inflammatory drugs. JAMA 1996; 276: 466-469
(1996)
JAMA
, vol.276
, pp. 466-469
Radford, M.G.1
Holley, K.E.2
Grande, J.P.3
9
0029052991
Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: A record linkage case-control study
Evans JM, McMahon AD, McGilchrist MM et al. Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case-control study. Br Med J 1995; 311: 22-26
(1995)
Br Med J
, vol.311
, pp. 22-26
Evans, J.M.1
McMahon, A.D.2
McGilchrist, M.M.3
10
0009654998
Non-steroidal anti-inflammatory drugs: How do they damage gastroduodenal rnucosa?
Scarpignato C. Non-steroidal anti-inflammatory drugs: how do they damage gastroduodenal rnucosa? Dig Dis 1995; 13[S1]: 9-39
(1995)
Dig Dis
, vol.13
, Issue.S1
, pp. 9-39
Scarpignato, C.1
11
0023178776
The clinical significance of inhibition of renal prostaglandin synthesis
Patrono C, Dunn MJ. The clinical significance of inhibition of renal prostaglandin synthesis. Kidney Int 1987; 32: 1-6
(1987)
Kidney Int
, vol.32
, pp. 1-6
Patrono, C.1
Dunn, M.J.2
12
0030476917
Clinical immunology of anti-rheumatic drugs
Balint G, Gergely P Jr. Clinical immunology of anti-rheumatic drugs. Inflam Res 1996; 45[S2]: 91-95
(1996)
Inflam Res
, vol.45
, Issue.S2
, pp. 91-95
Balint, G.1
Gergely P., Jr.2